|
|
Article: Kirin Buys Transgenic Cow Firm Hematech For $45M.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
Paying $45 million in cash, Kirin Brewery Co. Ltd. acquired Hematech LLC for its capabilities of producing bovine-derived human polyclonal antibodies.
Sioux Falls, S.D.-based Hematech opened its doors in 1998, and entered a research collaboration with Tokyo-based Kirin the following year.
"We had technology and expertise for cloning cows and doing genetic modification in cows, and in the bovine immune system," said James Robl, Hematech's president, chief scientific officer, director and co-founder. "They had expertise in manipulating the antibody genes using a microchromosome approach. So we put the two sets of technology together ...